Pacheco J, Hillman N, Lin J, Batata A
South Med J. 1983 Jul;76(7):932-4.
A patient had prolymphocytic leukemia and survived for 44 months. A partial remission for more than 11 months and a short complete remission were induced by agents commonly used for the treatment of acute myelocytic leukemia. However, surface markers identified the disease as of B-cell origin.
一名患有幼淋巴细胞白血病的患者存活了44个月。通过常用于治疗急性髓细胞白血病的药物诱导出了超过11个月的部分缓解和短暂的完全缓解。然而,表面标志物将该疾病确定为B细胞起源。